The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
Centers for Disease Control and Prevention (CDC) in the USA have released a study of lifetime risk of HIV, concluding that if HIV infection rates remain as they are black gay and bisexual men in Ameria have a 1 in 2 risk of being diagnosed in their lifetime and Latino gay men have a risk of 1 in 4.
In 30 years of HIV in Nigeria efforts to combat the virus have had limited success, and new infections are recorded daily especially among more at risk groups such as young people, sex workers and men who have sex with men.
Two recent studies show that vaginal rings are effective at cutting HIV infection rates among women. But the overall effectiveness was not significant - less than a third of infections were prevented.
John Hopkins is set to be the first hospital in the USA to conduct an HIV-positive to HIV-positive kidney transplant, and the first in the world to conduct a liver transplant between two HIV-positive people.
Significant disparities in condom use between countries has led UNAIDS to establish a new global target to make 20 billion condoms available by 2020.
An adult film actor has been infected with HIV during production in the USA, prompting the US Centers for Disease Control (CDC) to call on the industry to re-evaluate its approach to HIV prevention, as ‘testing alone is not sufficient to prevent occupational HIV transmission’.
In the run up to Valentines Day, the Thai government has launched a new condom promotion campaign, which aims to increase acceptance of, and reduce the social stigma associated with, young people carrying condoms.
The campaign, launched last week, forms part of the National Condom Strategy, which runs until 2019.
New research indicates that only 38% of black Americans living with HIV consistently remain in HIV care, compared to 50% for Hispanic/ Latino Americans, and 49% for white Americans.
Resistance to the commonly prescribed antiretroviral drug tenofovir is ‘surprisingly common’, according to findings published in the Lancet Infectious Diseases last week.